| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | kinase activity | CMPK1 CAD PDK1 GRK7 SPEG SRC MAP3K14 STYK1 SRMS PFKFB1 ACVR1 PFKFB4 ACVR1B ACVRL1 PFKP PIK3CG PDIK1L PI4KA GUCY2D TJP2 IRAK3 MAPK1 KIT DCLK1 | 6.16e-09 | 764 | 156 | 24 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | CMPK1 CAD PDK1 GRK7 SPEG SRC MAP3K14 STYK1 SRMS TENT5C PFKFB1 ACVR1 PFKFB4 ACVR1B ACVRL1 PFKP PNPT1 PIK3CG PDIK1L PI4KA GUCY2D TJP2 IRAK3 MAPK1 KIT DCLK1 | 1.75e-08 | 938 | 156 | 26 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | CAD PDK1 GRK7 SPEG SRC MAP3K14 STYK1 SRMS PFKFB1 ACVR1 PFKFB4 ACVR1B ACVRL1 PFKP PIK3CG PDIK1L PI4KA GUCY2D IRAK3 MAPK1 KIT DCLK1 | 3.51e-08 | 709 | 156 | 22 | GO:0016773 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 5.16e-08 | 14 | 156 | 5 | GO:0070679 | |
| GeneOntologyMolecularFunction | protein kinase activity | CAD PDK1 GRK7 SPEG SRC MAP3K14 STYK1 SRMS ACVR1 ACVR1B ACVRL1 PIK3CG PDIK1L GUCY2D IRAK3 MAPK1 KIT DCLK1 | 1.11e-06 | 600 | 156 | 18 | GO:0004672 |
| GeneOntologyMolecularFunction | store-operated calcium channel activity | 1.69e-06 | 12 | 156 | 4 | GO:0015279 | |
| GeneOntologyMolecularFunction | activin receptor activity, type I | 4.62e-06 | 5 | 156 | 3 | GO:0016361 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.54e-05 | 102 | 156 | 7 | GO:0043178 | |
| GeneOntologyMolecularFunction | phosphofructokinase activity | 1.60e-05 | 7 | 156 | 3 | GO:0008443 | |
| GeneOntologyMolecularFunction | activin receptor activity | 3.80e-05 | 9 | 156 | 3 | GO:0017002 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.99e-05 | 129 | 156 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | activin binding | 9.77e-05 | 12 | 156 | 3 | GO:0048185 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PMS1 MYH3 LONP2 ACTB MCM4 CHD2 RFC2 CLPB ABCB11 ABCD1 DNAH9 HSP90AB3P | 1.86e-04 | 441 | 156 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.87e-04 | 151 | 156 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | PDK1 GRK7 SPEG MAP3K14 ACVR1 ACVR1B ACVRL1 PIK3CG PDIK1L IRAK3 MAPK1 DCLK1 | 2.06e-04 | 446 | 156 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | ATP-dependent activity | PMS1 MYH3 LONP2 ACTB MCM4 CHD2 RFC2 ACSL1 CLPB SLC27A1 ABCB11 ABCD1 DNAH9 HSP90AB3P | 3.36e-04 | 614 | 156 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | oleoyl-CoA ligase activity | 3.60e-04 | 4 | 156 | 2 | GO:0090434 | |
| GeneOntologyMolecularFunction | 6-phosphofructo-2-kinase activity | 3.60e-04 | 4 | 156 | 2 | GO:0003873 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.75e-04 | 343 | 156 | 10 | GO:0005261 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 4.84e-04 | 20 | 156 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 5.61e-04 | 21 | 156 | 3 | GO:0019200 | |
| GeneOntologyMolecularFunction | fructose-2,6-bisphosphate 2-phosphatase activity | 5.97e-04 | 5 | 156 | 2 | GO:0004331 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 5.97e-04 | 5 | 156 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | fructose-6-phosphate binding | 5.97e-04 | 5 | 156 | 2 | GO:0070095 | |
| GeneOntologyMolecularFunction | glycerophosphodiester phosphodiesterase activity | 8.91e-04 | 6 | 156 | 2 | GO:0008889 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | PMS1 MYH3 RAP2B LONP2 ACTB MCM4 CHD2 ARHGAP35 RFC2 TUBB3 CLPB ABCB11 ABCD1 DNAH9 HSP90AB3P | 1.12e-03 | 775 | 156 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | lysophospholipase activity | 1.47e-03 | 29 | 156 | 3 | GO:0004622 | |
| GeneOntologyMolecularFunction | kinase binding | DOCK4 SRC ACTB ACTG1 NR4A3 PFKFB1 ACVR1 ACVRL1 STAT3 WDR45 KIDINS220 PER3 TJP2 IRAK3 MAPK1 LRBA TP73 | 1.54e-03 | 969 | 156 | 17 | GO:0019900 |
| GeneOntologyMolecularFunction | BMP receptor activity | 1.65e-03 | 8 | 156 | 2 | GO:0098821 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 2.11e-03 | 9 | 156 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PMS1 MYH3 RAP2B LONP2 ACTB MCM4 CHD2 ARHGAP35 RFC2 TUBB3 CLPB ABCB11 ABCD1 DNAH9 HSP90AB3P | 2.43e-03 | 839 | 156 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PMS1 MYH3 RAP2B LONP2 ACTB MCM4 CHD2 ARHGAP35 RFC2 TUBB3 CLPB ABCB11 ABCD1 DNAH9 HSP90AB3P | 2.46e-03 | 840 | 156 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PMS1 MYH3 RAP2B LONP2 ACTB MCM4 CHD2 ARHGAP35 RFC2 TUBB3 CLPB ABCB11 ABCD1 DNAH9 HSP90AB3P | 2.46e-03 | 840 | 156 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | sugar-phosphatase activity | 2.62e-03 | 10 | 156 | 2 | GO:0050308 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ADAM18 RTN4 SRC ACVR1 PFKP PAICS ADAM22 CNTN6 DST PI4KA TJP2 CDH13 | 2.66e-03 | 599 | 156 | 12 | GO:0050839 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 3.18e-03 | 11 | 156 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | carbohydrate phosphatase activity | 3.18e-03 | 11 | 156 | 2 | GO:0019203 | |
| GeneOntologyMolecularFunction | phosphatidyl phospholipase B activity | 3.18e-03 | 11 | 156 | 2 | GO:0102545 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 3.18e-03 | 11 | 156 | 2 | GO:0047676 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.32e-03 | 459 | 156 | 10 | GO:0005216 | |
| GeneOntologyMolecularFunction | protein kinase binding | DOCK4 SRC ACTB ACTG1 NR4A3 ACVR1 ACVRL1 STAT3 WDR45 KIDINS220 TJP2 IRAK3 MAPK1 LRBA TP73 | 3.53e-03 | 873 | 156 | 15 | GO:0019901 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.64e-03 | 465 | 156 | 10 | GO:0046873 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | MYH3 CMPK1 CAD PDK1 ACLY SRC PFKFB1 PFKFB4 PFKP PAICS GDE1 STAT3 ACSL1 MTMR6 PNPLA6 SULT2B1 PIK3CG PI4KA SLC27A1 GUCY2D GPCPD1 TJP2 ABCD1 PNPLA7 MAPK1 | 1.38e-06 | 1142 | 155 | 25 | GO:0019637 |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | MYH3 CMPK1 CAD PDK1 ACLY SRC PFKFB1 PFKP PAICS STAT3 ACSL1 SULT2B1 GUCY2D TJP2 ABCD1 | 1.24e-05 | 533 | 155 | 15 | GO:0009259 |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | MYH3 CMPK1 CAD PDK1 ACLY SRC PFKFB1 PFKP PAICS STAT3 ACSL1 SULT2B1 GUCY2D TJP2 ABCD1 | 1.44e-05 | 540 | 155 | 15 | GO:0019693 |
| GeneOntologyBiologicalProcess | protein localization to cell-cell junction | 2.90e-05 | 24 | 155 | 4 | GO:0150105 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 4.82e-05 | 53 | 155 | 5 | GO:0045747 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | MYH3 CMPK1 CAD PDK1 ACLY SRC PFKFB1 PFKP PAICS STAT3 ACSL1 SULT2B1 GUCY2D TJP2 ABCD1 MAPK1 | 5.93e-05 | 684 | 155 | 16 | GO:0009117 |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | MYH3 CMPK1 CAD PDK1 ACLY SRC PFKFB1 PFKP PAICS STAT3 ACSL1 SULT2B1 GUCY2D TJP2 ABCD1 MAPK1 | 6.69e-05 | 691 | 155 | 16 | GO:0006753 |
| GeneOntologyBiologicalProcess | ribonucleoside diphosphate metabolic process | 1.05e-04 | 143 | 155 | 7 | GO:0009185 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | MYH3 PDK1 ACLY SRC PFKFB1 PFKP PAICS STAT3 ACSL1 SULT2B1 GUCY2D TJP2 ABCD1 | 1.35e-04 | 512 | 155 | 13 | GO:0009150 |
| GeneOntologyBiologicalProcess | nucleoside diphosphate metabolic process | 1.36e-04 | 149 | 155 | 7 | GO:0009132 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | PSAP ACER1 LONP2 CYP19A1 GDE1 PNPLA6 PIK3CG GPCPD1 ABCB11 ABCD1 PNPLA7 | 1.52e-04 | 382 | 155 | 11 | GO:0016042 |
| GeneOntologyBiologicalProcess | glycerophospholipid catabolic process | 1.67e-04 | 37 | 155 | 4 | GO:0046475 | |
| GeneOntologyBiologicalProcess | glycerolipid catabolic process | 1.83e-04 | 70 | 155 | 5 | GO:0046503 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | ACER1 PDK1 GRK7 SYNE1 TRPC3 RTN4 SRC ACTB ACVRL1 FBXL3 STAT3 ITPR1 ERCC8 PER3 CLPB LOXL2 SLC27A1 GUCY2D KCNQ2 SLITRK6 KIT NIPBL HSP90AB3P | 2.15e-04 | 1361 | 155 | 23 | GO:0009628 |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | MYH3 CMPK1 CAD PDK1 ACLY SRC PFKFB1 PFKP PAICS STAT3 ACSL1 SULT2B1 GUCY2D TJP2 ABCD1 MAPK1 | 2.22e-04 | 767 | 155 | 16 | GO:0055086 |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | DOCK1 DOCK4 RTN4 SRC ACTG1 NR4A3 ACVR1 ACVR1B STAT3 PIK3CG DAAM2 MAPK1 KIT NIPBL CDH13 | 2.30e-04 | 691 | 155 | 15 | GO:0030335 |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | 2.83e-04 | 281 | 155 | 9 | GO:0046434 | |
| GeneOntologyBiologicalProcess | nucleobase biosynthetic process | 3.13e-04 | 18 | 155 | 3 | GO:0046112 | |
| GeneOntologyBiologicalProcess | animal organ regeneration | 3.24e-04 | 79 | 155 | 5 | GO:0031100 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 3.33e-04 | 4 | 155 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | UDP biosynthetic process | 3.33e-04 | 4 | 155 | 2 | GO:0006225 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside diphosphate biosynthetic process | 3.33e-04 | 4 | 155 | 2 | GO:0009194 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 3.37e-04 | 228 | 155 | 8 | GO:0046777 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | MYH3 CMPK1 CAD PSAP B4GAT1 PDK1 ACLY SRC PFKFB1 PFKFB4 PFKP PAICS STAT3 ACSL1 SULT2B1 HS2ST1 GUCY2D TJP2 ABCD1 KIT ALG13 | 3.47e-04 | 1226 | 155 | 21 | GO:1901135 |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.52e-04 | 124 | 155 | 6 | GO:0034109 | |
| GeneOntologyBiologicalProcess | nucleobase metabolic process | 3.60e-04 | 45 | 155 | 4 | GO:0009112 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | DOCK1 DOCK4 RTN4 SRC ACTG1 NR4A3 ACVR1 ACVR1B STAT3 PIK3CG DAAM2 MAPK1 KIT NIPBL CDH13 | 3.82e-04 | 725 | 155 | 15 | GO:2000147 |
| GeneOntologyCellularComponent | cation channel complex | 6.67e-05 | 235 | 155 | 9 | GO:0034703 | |
| HumanPheno | Limitation of joint mobility | MYH3 COL12A1 SYNE1 SPEG ACTB ACTG1 ACVR1 RFC2 STAT4 ERCC8 PNPT1 GTF2I DST PI4KA HS2ST1 GTF2IRD2 MAPK1 NIPBL UNC80 | 1.97e-06 | 432 | 68 | 19 | HP:0001376 |
| HumanPheno | Limited hip movement | 7.40e-06 | 78 | 68 | 8 | HP:0008800 | |
| HumanPheno | Hip contracture | 1.52e-05 | 62 | 68 | 7 | HP:0003273 | |
| HumanPheno | Adducted thumb | 1.67e-05 | 114 | 68 | 9 | HP:0001181 | |
| HumanPheno | Abdominal pain | PMS1 TRPC6 RFC2 STAT3 STAT4 PNPT1 GTF2I CLPB PIK3CG GTF2IRD2 ABCB11 DAAM2 ABCD1 KIT IL23R | 4.11e-05 | 350 | 68 | 15 | HP:0002027 |
| HumanPheno | Abnormality of facial soft tissue | PMS1 COL12A1 SYNE1 SPEG TRPC6 ACTB ACTG1 RFC2 ITPR1 ERCC8 PNPT1 TUBB3 GTF2I WASHC5 PI4KA GTF2IRD2 DAAM2 ABCD1 UNC80 | 4.82e-05 | 538 | 68 | 19 | HP:0011799 |
| HumanPheno | Gastrointestinal ulcer | 5.69e-05 | 52 | 68 | 6 | HP:0034274 | |
| HumanPheno | Myokymia | 1.20e-04 | 20 | 68 | 4 | HP:0002411 | |
| HumanPheno | Gastric ulcer | 1.30e-04 | 38 | 68 | 5 | HP:0002592 | |
| HumanPheno | Wrist flexion contracture | 1.30e-04 | 38 | 68 | 5 | HP:0001239 | |
| HumanPheno | Peptic ulcer | 1.30e-04 | 38 | 68 | 5 | HP:0004398 | |
| HumanPheno | Abnormal gastric mucosa morphology | 1.41e-04 | 61 | 68 | 6 | HP:0004295 | |
| HumanPheno | Profound static encephalopathy | 1.76e-04 | 2 | 68 | 2 | HP:0007069 | |
| HumanPheno | Elfin facies | 1.77e-04 | 22 | 68 | 4 | HP:0004428 | |
| HumanPheno | Abnormality of the ankle | COL12A1 PSAP SYNE1 RFC2 STAT4 PNPT1 GTF2I PI4KA GTF2IRD2 ABCD1 | 1.98e-04 | 192 | 68 | 10 | HP:0003028 |
| HumanPheno | Cerebral ischemia | 2.02e-04 | 123 | 68 | 8 | HP:0002637 | |
| HumanPheno | Tissue ischemia | 2.02e-04 | 123 | 68 | 8 | HP:0033401 | |
| HumanPheno | Atrophy/Degeneration involving the corticospinal tracts | 2.12e-04 | 42 | 68 | 5 | HP:0007372 | |
| HumanPheno | Death in early adulthood | 2.12e-04 | 42 | 68 | 5 | HP:0100613 | |
| HumanPheno | Heterochromia iridis | 2.52e-04 | 24 | 68 | 4 | HP:0001100 | |
| HumanPheno | Asymmetry of iris pigmentation | 2.52e-04 | 24 | 68 | 4 | HP:0200064 | |
| HumanPheno | Vertebral segmentation defect | 2.62e-04 | 162 | 68 | 9 | HP:0003422 | |
| HumanPheno | Biliary tract abnormality | PSAP ACVRL1 RFC2 ITPR1 GTF2I IL36RN PI4KA GTF2IRD2 TJP2 ABCB11 ABCD1 | 2.65e-04 | 238 | 68 | 11 | HP:0001080 |
| HumanPheno | Death in adulthood | 2.65e-04 | 44 | 68 | 5 | HP:0033763 | |
| HumanPheno | Dysarthria | PMS1 PSAP SYNE1 SPEG ACTB RFC2 CCDC141 FBXL3 ITPR1 ERCC8 PNPT1 TUBB3 GTF2I PNPLA6 CLPB WASHC5 PI4KA GTF2IRD2 ABCD1 | 2.70e-04 | 611 | 68 | 19 | HP:0001260 |
| HumanPheno | Limb joint contracture | MYH3 DLG5 COL12A1 SYNE1 SPEG STAT3 ERCC8 PNPT1 TUBB3 RTL1 PI4KA HS2ST1 ABCD1 MAPK1 NIPBL UNC80 | 3.32e-04 | 469 | 68 | 16 | HP:0003121 |
| HumanPheno | Abnormal shoulder morphology | MYH3 COL12A1 PSAP SYNE1 SPEG RFC2 STAT4 ITPR1 GTF2I RTL1 GTF2IRD2 | 3.53e-04 | 246 | 68 | 11 | HP:0003043 |
| HumanPheno | Abnormal uvea morphology | PSAP B4GAT1 ACTB ACTG1 ACVRL1 RFC2 STAT4 ITPR1 ERCC8 TUBB3 WDR45 GTF2I DST PNPLA6 IL36RN HMCN1 WASHC5 RTL1 HS2ST1 GUCY2D GTF2IRD2 MAPK1 LRBA KIT IL23R | 3.98e-04 | 965 | 68 | 25 | HP:0000553 |
| Domain | TRP_channel | 1.59e-08 | 11 | 154 | 5 | IPR004729 | |
| Domain | TRP_2 | 6.58e-08 | 6 | 154 | 4 | PF08344 | |
| Domain | TRP_dom | 6.58e-08 | 6 | 154 | 4 | IPR013555 | |
| Domain | Kinase-like_dom | GRK7 SPEG SRC MAP3K14 STYK1 SRMS ACVR1 ACVR1B ARHGAP35 ACVRL1 DST PIK3CG PDIK1L PI4KA GUCY2D IRAK3 MAPK1 KIT DCLK1 | 1.13e-07 | 542 | 154 | 19 | IPR011009 |
| Domain | TRPC_channel | 1.53e-07 | 7 | 154 | 4 | IPR002153 | |
| Domain | Ion_trans_dom | 4.32e-07 | 114 | 154 | 9 | IPR005821 | |
| Domain | Ion_trans | 4.32e-07 | 114 | 154 | 9 | PF00520 | |
| Domain | - | 2.19e-06 | 4 | 154 | 3 | 3.90.1460.10 | |
| Domain | GTF2I | 2.19e-06 | 4 | 154 | 3 | PS51139 | |
| Domain | GTF2I | 2.19e-06 | 4 | 154 | 3 | PF02946 | |
| Domain | GTF2I | 2.19e-06 | 4 | 154 | 3 | IPR004212 | |
| Domain | Prot_kinase_dom | GRK7 SPEG SRC MAP3K14 STYK1 SRMS ACVR1 ACVR1B ACVRL1 PDIK1L GUCY2D IRAK3 MAPK1 KIT DCLK1 | 1.32e-05 | 489 | 154 | 15 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | GRK7 SPEG SRC MAP3K14 STYK1 SRMS ACVR1 ACVR1B ACVRL1 PDIK1L GUCY2D IRAK3 MAPK1 KIT DCLK1 | 1.45e-05 | 493 | 154 | 15 | PS50011 |
| Domain | GS_dom | 1.88e-05 | 7 | 154 | 3 | IPR003605 | |
| Domain | GS | 1.88e-05 | 7 | 154 | 3 | PS51256 | |
| Domain | TGF_beta_GS | 1.88e-05 | 7 | 154 | 3 | PF08515 | |
| Domain | GS | 1.88e-05 | 7 | 154 | 3 | SM00467 | |
| Domain | PROTEIN_KINASE_ATP | GRK7 SPEG SRC MAP3K14 STYK1 SRMS ACVR1 ACVR1B ACVRL1 PDIK1L IRAK3 MAPK1 KIT DCLK1 | 2.76e-05 | 459 | 154 | 14 | PS00107 |
| Domain | - | 4.59e-05 | 48 | 154 | 5 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 6.18e-05 | 51 | 154 | 5 | IPR014710 | |
| Domain | UPF0028 | 6.75e-05 | 2 | 154 | 2 | PS01237 | |
| Domain | Protein_kinase_ATP_BS | GRK7 SPEG SRC MAP3K14 SRMS ACVR1 ACVR1B ACVRL1 PDIK1L MAPK1 KIT DCLK1 | 7.39e-05 | 379 | 154 | 12 | IPR017441 |
| Domain | TGFB_receptor | 1.15e-04 | 12 | 154 | 3 | IPR000333 | |
| Domain | CNMP_BINDING_1 | 1.34e-04 | 32 | 154 | 4 | PS00888 | |
| Domain | CNMP_BINDING_2 | 1.34e-04 | 32 | 154 | 4 | PS00889 | |
| Domain | - | DLG5 CMPK1 RAP2B LONP2 MCM4 CHD2 PFKFB1 PFKFB4 ARHGAP35 RFC2 CLPB SULT2B1 HS2ST1 TJP2 ABCB11 ABCD1 DNAH9 | 1.46e-04 | 746 | 154 | 17 | 3.40.50.300 |
| Domain | cNMP | 1.70e-04 | 34 | 154 | 4 | SM00100 | |
| Domain | cNMP_binding | 1.70e-04 | 34 | 154 | 4 | PF00027 | |
| Domain | cNMP-bd_dom | 1.91e-04 | 35 | 154 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.91e-04 | 35 | 154 | 4 | PS50042 | |
| Domain | AAA | 1.93e-04 | 144 | 154 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.93e-04 | 144 | 154 | 7 | IPR003593 | |
| Domain | TFIID-31 | 2.02e-04 | 3 | 154 | 2 | IPR003162 | |
| Domain | TFIID-31kDa | 2.02e-04 | 3 | 154 | 2 | PF02291 | |
| Domain | - | TRPC7 TRPC1 TRPC3 TRPC6 KIDINS220 CLPB ANKRD28 TRPV6 ANKRD52 | 2.21e-04 | 248 | 154 | 9 | 1.25.40.20 |
| Domain | P-loop_NTPase | MYH3 DLG5 CMPK1 RAP2B LONP2 MCM4 CHD2 PFKFB1 PFKFB4 ARHGAP35 RFC2 CLPB SULT2B1 HS2ST1 TJP2 ABCB11 ABCD1 DNAH9 | 2.22e-04 | 848 | 154 | 18 | IPR027417 |
| Domain | ANK | TRPC7 TRPC1 TRPC3 TRPC6 KIDINS220 CLPB ANKRD28 TRPV6 ANKRD52 | 2.42e-04 | 251 | 154 | 9 | SM00248 |
| Domain | ANK_REPEAT | TRPC7 TRPC1 TRPC3 TRPC6 KIDINS220 CLPB ANKRD28 TRPV6 ANKRD52 | 2.56e-04 | 253 | 154 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | TRPC7 TRPC1 TRPC3 TRPC6 KIDINS220 CLPB ANKRD28 TRPV6 ANKRD52 | 2.64e-04 | 254 | 154 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | TRPC7 TRPC1 TRPC3 TRPC6 KIDINS220 CLPB ANKRD28 TRPV6 ANKRD52 | 2.64e-04 | 254 | 154 | 9 | PS50297 |
| Domain | cNMP-bd-like | 2.64e-04 | 38 | 154 | 4 | IPR018490 | |
| Domain | Ankyrin_rpt | TRPC7 TRPC1 TRPC3 TRPC6 KIDINS220 CLPB ANKRD28 TRPV6 ANKRD52 | 3.31e-04 | 262 | 154 | 9 | IPR002110 |
| Domain | 6Phosfructo_kin | 4.01e-04 | 4 | 154 | 2 | IPR013079 | |
| Domain | 6Pfruct_kin | 4.01e-04 | 4 | 154 | 2 | IPR003094 | |
| Domain | 6PF2K | 4.01e-04 | 4 | 154 | 2 | PF01591 | |
| Domain | - | 4.10e-04 | 18 | 154 | 3 | 3.30.470.20 | |
| Domain | Ank_2 | 4.20e-04 | 215 | 154 | 8 | PF12796 | |
| Domain | SH3 | 4.33e-04 | 216 | 154 | 8 | PS50002 | |
| Domain | SH3_domain | 4.89e-04 | 220 | 154 | 8 | IPR001452 | |
| Domain | Ank | 6.18e-04 | 228 | 154 | 8 | PF00023 | |
| Domain | DOCK_N | 6.65e-04 | 5 | 154 | 2 | PF16172 | |
| Domain | DOCK_N | 6.65e-04 | 5 | 154 | 2 | IPR032376 | |
| Domain | Pkinase_Tyr | 7.05e-04 | 129 | 154 | 6 | PF07714 | |
| Domain | Ser/Thr_kinase_AS | GRK7 SPEG MAP3K14 ACVR1 ACVR1B ACVRL1 PDIK1L IRAK3 MAPK1 DCLK1 | 7.73e-04 | 357 | 154 | 10 | IPR008271 |
| Domain | PROTEIN_KINASE_ST | GRK7 SPEG MAP3K14 ACVR1 ACVR1B ACVRL1 PDIK1L IRAK3 MAPK1 DCLK1 | 8.59e-04 | 362 | 154 | 10 | PS00108 |
| Domain | Spectrin | 8.63e-04 | 23 | 154 | 3 | PF00435 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.00e-03 | 138 | 154 | 6 | IPR001245 | |
| Domain | ATPase_AAA_core | 1.02e-03 | 54 | 154 | 4 | IPR003959 | |
| Domain | Pkinase | GRK7 SPEG MAP3K14 ACVR1 ACVR1B ACVRL1 PDIK1L IRAK3 MAPK1 DCLK1 | 1.26e-03 | 381 | 154 | 10 | PF00069 |
| Domain | STAT_TF_DNA-bd_sub | 1.38e-03 | 7 | 154 | 2 | IPR012345 | |
| Domain | STAT | 1.38e-03 | 7 | 154 | 2 | IPR001217 | |
| Domain | STAT_int | 1.38e-03 | 7 | 154 | 2 | SM00964 | |
| Domain | GP_PDE_dom | 1.38e-03 | 7 | 154 | 2 | IPR030395 | |
| Domain | STAT_TF_DNA-bd | 1.38e-03 | 7 | 154 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.38e-03 | 7 | 154 | 2 | PF02864 | |
| Domain | STAT_int | 1.38e-03 | 7 | 154 | 2 | PF02865 | |
| Domain | - | 1.38e-03 | 7 | 154 | 2 | 1.10.532.10 | |
| Domain | GlyceroP-diester-Pdiesterase | 1.38e-03 | 7 | 154 | 2 | IPR004129 | |
| Domain | STAT_alpha | 1.38e-03 | 7 | 154 | 2 | PF01017 | |
| Domain | - | 1.38e-03 | 7 | 154 | 2 | 1.20.1050.20 | |
| Domain | GDPD | 1.38e-03 | 7 | 154 | 2 | PF03009 | |
| Domain | STAT_TF_prot_interaction | 1.38e-03 | 7 | 154 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.38e-03 | 7 | 154 | 2 | IPR015988 | |
| Domain | - | 1.38e-03 | 7 | 154 | 2 | 2.60.40.630 | |
| Domain | RAWUL | 1.38e-03 | 7 | 154 | 2 | IPR032443 | |
| Domain | GP_PDE | 1.38e-03 | 7 | 154 | 2 | PS51704 | |
| Domain | RAWUL | 1.38e-03 | 7 | 154 | 2 | PF16207 | |
| Domain | Spectrin_repeat | 1.72e-03 | 29 | 154 | 3 | IPR002017 | |
| Domain | STAT_TF_alpha | 1.83e-03 | 8 | 154 | 2 | IPR013800 | |
| Domain | PH-BEACH_dom | 1.83e-03 | 8 | 154 | 2 | IPR023362 | |
| Domain | ACTINS_1 | 1.83e-03 | 8 | 154 | 2 | PS00406 | |
| Domain | - | 1.83e-03 | 8 | 154 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.83e-03 | 8 | 154 | 2 | PS51783 | |
| Domain | ARM-type_fold | 2.04e-03 | 339 | 154 | 9 | IPR016024 | |
| Domain | ATP_grasp_subdomain_2 | 2.09e-03 | 31 | 154 | 3 | IPR013816 | |
| Domain | SH3 | 2.12e-03 | 216 | 154 | 7 | SM00326 | |
| Domain | fn3 | 2.27e-03 | 162 | 154 | 6 | PF00041 | |
| Domain | PI3Ka | 2.34e-03 | 9 | 154 | 2 | PF00613 | |
| Domain | Patatin | 2.34e-03 | 9 | 154 | 2 | PF01734 | |
| Domain | BEACH | 2.34e-03 | 9 | 154 | 2 | PS50197 | |
| Domain | Beach | 2.34e-03 | 9 | 154 | 2 | PF02138 | |
| Domain | - | 2.34e-03 | 9 | 154 | 2 | 1.10.1540.10 | |
| Domain | PNPLA | 2.34e-03 | 9 | 154 | 2 | PS51635 | |
| Domain | Beach | 2.34e-03 | 9 | 154 | 2 | SM01026 | |
| Domain | PI3Ka | 2.34e-03 | 9 | 154 | 2 | SM00145 | |
| Domain | PG/BPGM_mutase_AS | 2.34e-03 | 9 | 154 | 2 | IPR001345 | |
| Domain | Patatin/PLipase_A2-rel | 2.34e-03 | 9 | 154 | 2 | IPR002641 | |
| Domain | BEACH_dom | 2.34e-03 | 9 | 154 | 2 | IPR000409 | |
| Domain | - | 2.34e-03 | 9 | 154 | 2 | 1.25.40.70 | |
| Domain | Ribosomal_S5_D2-typ_fold | 2.73e-03 | 34 | 154 | 3 | IPR020568 | |
| Pathway | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING | 1.04e-06 | 10 | 121 | 4 | M27330 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.91e-06 | 44 | 121 | 6 | M875 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 2.44e-06 | 26 | 121 | 5 | M39687 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 2.44e-06 | 26 | 121 | 5 | MM15896 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 3.48e-06 | 13 | 121 | 4 | MM14553 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.60e-06 | 28 | 121 | 5 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 3.60e-06 | 28 | 121 | 5 | M27241 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 8.68e-06 | 16 | 121 | 4 | M26945 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.50e-05 | 37 | 121 | 5 | MM15102 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM | 2.11e-05 | 7 | 121 | 3 | M27657 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.18e-05 | 43 | 121 | 5 | M41827 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 3.56e-05 | 44 | 121 | 5 | MM15678 | |
| Pathway | REACTOME_INTERLEUKIN_23_SIGNALING | 4.99e-05 | 9 | 121 | 3 | M27896 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 5.68e-05 | 25 | 121 | 4 | M39794 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 5.68e-05 | 25 | 121 | 4 | MM14511 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.05e-05 | 49 | 121 | 5 | M891 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY | 7.08e-05 | 10 | 121 | 3 | M47907 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 7.30e-05 | 257 | 121 | 10 | MM15454 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.78e-05 | 27 | 121 | 4 | MM15053 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 7.78e-05 | 27 | 121 | 4 | M12123 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 8.11e-05 | 121 | 121 | 7 | M872 | |
| Pathway | REACTOME_PI_METABOLISM | 8.31e-05 | 84 | 121 | 6 | M676 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 9.02e-05 | 28 | 121 | 4 | M924 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY | 1.66e-04 | 13 | 121 | 3 | M47723 | |
| Pathway | BIOCARTA_MET_PATHWAY | 1.74e-04 | 33 | 121 | 4 | M19358 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 1.74e-04 | 33 | 121 | 4 | M39532 | |
| Pathway | KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM | 1.96e-04 | 34 | 121 | 4 | M15898 | |
| Pathway | WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING | 1.96e-04 | 34 | 121 | 4 | M39383 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.06e-04 | 99 | 121 | 6 | MM14910 | |
| Pathway | WP_FOCAL_ADHESION | 2.07e-04 | 187 | 121 | 8 | MM15913 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.90e-04 | 68 | 121 | 5 | MM14968 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.99e-04 | 106 | 121 | 6 | M27200 | |
| Pathway | WP_FOCAL_ADHESION | 3.16e-04 | 199 | 121 | 8 | M39402 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.37e-04 | 39 | 121 | 4 | MM15272 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 3.55e-04 | 71 | 121 | 5 | MM15947 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.72e-04 | 40 | 121 | 4 | M27557 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 4.14e-04 | 261 | 121 | 9 | M1077 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 4.49e-04 | 42 | 121 | 4 | M41828 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK1 DOCK4 FNBP1 DLG5 SRC ACTB ACTG1 ARHGAP35 KIDINS220 DST GFOD1 TJP2 | 4.86e-04 | 450 | 121 | 12 | M27078 |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 4.92e-04 | 43 | 121 | 4 | MM15679 | |
| Pathway | REACTOME_PI_METABOLISM | 5.17e-04 | 77 | 121 | 5 | MM14590 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 5.38e-04 | 44 | 121 | 4 | MM14606 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 5.86e-04 | 45 | 121 | 4 | M27623 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 6.32e-04 | 20 | 121 | 3 | M39002 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 6.93e-04 | 47 | 121 | 4 | M39380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 7.18e-04 | 5 | 121 | 2 | M49034 | |
| Pathway | WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER | 7.18e-04 | 5 | 121 | 2 | M39621 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 7.33e-04 | 21 | 121 | 3 | M47722 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PSAP ACER1 ACLY CYP19A1 GDE1 ACSL1 MTMR6 PNPLA6 PIK3CG PI4KA SLC27A1 OSBPL7 GPCPD1 ABCB11 ABCD1 PNPLA7 | 7.42e-04 | 757 | 121 | 16 | M27451 |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 7.51e-04 | 48 | 121 | 4 | MM15479 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 8.43e-04 | 22 | 121 | 3 | M39795 | |
| Pathway | PID_PDGFRB_PATHWAY | 8.51e-04 | 129 | 121 | 6 | M186 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 9.45e-04 | 51 | 121 | 4 | M26972 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 9.64e-04 | 23 | 121 | 3 | M18719 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 9.64e-04 | 23 | 121 | 3 | MM1480 | |
| Pathway | BIOCARTA_BAD_PATHWAY | 1.09e-03 | 24 | 121 | 3 | MM1467 | |
| Pathway | REACTOME_SIGNALING_BY_PTK6 | 1.17e-03 | 54 | 121 | 4 | M29742 | |
| Pathway | REACTOME_HEMOSTASIS | DOCK1 DOCK4 TRPC7 PSAP TRPC3 TRPC6 SRC ACTG1 ITPR1 MMRN1 TUBB3 PIK3CG MAPK1 | 1.23e-03 | 571 | 121 | 13 | MM14472 |
| Pathway | BIOCARTA_BAD_PATHWAY | 1.24e-03 | 25 | 121 | 3 | M85 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | DOCK1 TRPC7 TRPC1 TRPC3 TRPC6 SRC ACTB ACTG1 ARHGAP35 CNTN6 TUBB3 KCNQ2 MAPK1 | 1.31e-03 | 575 | 121 | 13 | M29853 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK1 DOCK4 FNBP1 DLG5 SRC ACTB ACTG1 ARHGAP35 TUBB3 KIDINS220 DST GFOD1 TJP2 MAPK1 | 1.33e-03 | 649 | 121 | 14 | MM15690 |
| Pathway | PID_ALK1_PATHWAY | 1.39e-03 | 26 | 121 | 3 | M185 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK1 DOCK4 FNBP1 DLG5 ACTB ACTG1 ARHGAP35 KIDINS220 DST GFOD1 TJP2 | 1.39e-03 | 439 | 121 | 11 | MM15595 |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 1.44e-03 | 57 | 121 | 4 | M19888 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.45e-03 | 143 | 121 | 6 | M27107 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.54e-03 | 98 | 121 | 5 | M776 | |
| Pathway | WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING | 1.55e-03 | 27 | 121 | 3 | M39609 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.63e-03 | 59 | 121 | 4 | M39350 | |
| Pathway | PID_FAK_PATHWAY | 1.63e-03 | 59 | 121 | 4 | M281 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.64e-03 | 199 | 121 | 7 | M7253 | |
| Pubmed | Heterogeneous distribution of TRPC proteins in the embryonic cortex. | 4.35e-10 | 10 | 157 | 5 | 18989690 | |
| Pubmed | CAD RAP2B PDK1 ACLY SYNE1 RTN4 ACTB ACTG1 ARHGAP35 PFKP ADAM22 JMY TUBB3 KIDINS220 DST PNPLA6 COX5A WASHC5 PI4KA KIAA1217 SLC27A1 TJP2 KCNQ2 TMED9 MAPK1 DCLK1 | 1.44e-09 | 1431 | 157 | 26 | 37142655 | |
| Pubmed | CAD LONP2 ACLY ACTB RNF149 ACTG1 MCM4 FNDC3A PFKP CCDC88B PAICS ITPR1 ACSL1 GTF2I KIDINS220 PNPLA6 PIK3CG PI4KA SLC27A1 HS2ST1 CLPTM1 ABCD1 LRBA | 3.19e-09 | 1168 | 157 | 23 | 19946888 | |
| Pubmed | MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC. | 1.38e-08 | 7 | 157 | 4 | 15757897 | |
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 36592529 | ||
| Pubmed | Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models. | 1.38e-08 | 7 | 157 | 4 | 15336983 | |
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 32350291 | ||
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 38835669 | ||
| Pubmed | 1.38e-08 | 7 | 157 | 4 | 36257322 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.88e-08 | 38 | 157 | 6 | 30786075 | |
| Pubmed | 2.76e-08 | 8 | 157 | 4 | 15199065 | ||
| Pubmed | Subunit composition of mammalian transient receptor potential channels in living cells. | 2.76e-08 | 8 | 157 | 4 | 12032305 | |
| Pubmed | 2.76e-08 | 8 | 157 | 4 | 25471572 | ||
| Pubmed | Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. | 4.95e-08 | 9 | 157 | 4 | 14505576 | |
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 15623527 | ||
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 11290752 | ||
| Pubmed | 4.95e-08 | 9 | 157 | 4 | 17480026 | ||
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 6.97e-08 | 24 | 157 | 5 | 33884443 | |
| Pubmed | 8.22e-08 | 10 | 157 | 4 | 27177420 | ||
| Pubmed | 8.69e-08 | 25 | 157 | 5 | 16382100 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 16529812 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 29330562 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 32097940 | ||
| Pubmed | IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity. | 9.02e-08 | 3 | 157 | 3 | 28878115 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 28526717 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 15972814 | ||
| Pubmed | NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation. | 9.02e-08 | 3 | 157 | 3 | 32871210 | |
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 30015929 | ||
| Pubmed | 9.02e-08 | 3 | 157 | 3 | 36569761 | ||
| Pubmed | 1.31e-07 | 27 | 157 | 5 | 16460286 | ||
| Pubmed | 2.77e-07 | 13 | 157 | 4 | 22051675 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 23229069 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 12356946 | ||
| Pubmed | The role of cGMP/cGKI signalling and Trpc channels in regulation of vascular tone. | 3.60e-07 | 4 | 157 | 3 | 23832809 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 30017393 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 28636132 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 22899722 | ||
| Pubmed | The contribution of TRPC1, TRPC3, TRPC5 and TRPC6 to touch and hearing. | 3.60e-07 | 4 | 157 | 3 | 26520460 | |
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 17823943 | ||
| Pubmed | 3.60e-07 | 4 | 157 | 3 | 21328569 | ||
| Pubmed | 3.77e-07 | 33 | 157 | 5 | 19834762 | ||
| Pubmed | 5.12e-07 | 35 | 157 | 5 | 18498732 | ||
| Pubmed | Enhanced capacitative calcium entry and TRPC channel gene expression in human LES smooth muscle. | 8.97e-07 | 5 | 157 | 3 | 12736151 | |
| Pubmed | TRPC channels are necessary mediators of pathologic cardiac hypertrophy. | 8.97e-07 | 5 | 157 | 3 | 20351294 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 30452936 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 18436303 | ||
| Pubmed | TRPC3 channels are required for synaptic transmission and motor coordination. | 8.97e-07 | 5 | 157 | 3 | 18701065 | |
| Pubmed | Formation of novel TRPC channels by complex subunit interactions in embryonic brain. | 8.97e-07 | 5 | 157 | 3 | 12857742 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 21261756 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 8397373 | ||
| Pubmed | JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase. | 8.97e-07 | 5 | 157 | 3 | 11313464 | |
| Pubmed | 9.09e-07 | 17 | 157 | 4 | 22411552 | ||
| Pubmed | 1.66e-06 | 44 | 157 | 5 | 19322198 | ||
| Pubmed | trp, a novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. | 1.79e-06 | 6 | 157 | 3 | 8646775 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 32414784 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 25347706 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 11390792 | ||
| Pubmed | Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. | 1.83e-06 | 20 | 157 | 4 | 21421818 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CNNM2 ACLY RTN4 MCM4 PFKP PAICS ACSL1 MTMR6 GTF2I KIDINS220 CLPB TJP2 ANKRD28 MAPK1 TAF9 ANKRD52 HSP90AB3P | 2.18e-06 | 974 | 157 | 17 | 28675297 |
| Pubmed | 2.25e-06 | 21 | 157 | 4 | 30270038 | ||
| Pubmed | DOCK4 CMPK1 CAD PDK1 FNDC3A RFC2 STAT3 PNPT1 NLN PNPLA6 HS2ST1 CLPTM1 TMED9 MAPK1 | 3.10e-06 | 686 | 157 | 14 | 28380382 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 12065756 | ||
| Pubmed | Mechanism of stretch-induced activation of the mechanotransducer zyxin in vascular cells. | 3.12e-06 | 7 | 157 | 3 | 23233529 | |
| Pubmed | 3.31e-06 | 23 | 157 | 4 | 26300262 | ||
| Pubmed | 3.31e-06 | 23 | 157 | 4 | 26870752 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DOCK1 FNBP1 ANXA4 SRC CHD2 CTIF PFKFB1 PFKFB4 ARHGAP35 PCGF3 GDE1 RANBP17 GTF2I KIDINS220 PNPLA6 LOXL2 KIAA1217 HS2ST1 PNPLA7 LRBA NSMAF | 3.84e-06 | 1489 | 157 | 21 | 28611215 |
| Pubmed | 3.99e-06 | 142 | 157 | 7 | 30809309 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CMPK1 CAD ACLY SYNE1 ANXA4 RTN4 ACTB PFKP PAICS SPAG5 TUBB3 DST DAAM2 LRBA ALG13 | 4.22e-06 | 807 | 157 | 15 | 30575818 |
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 19914172 | ||
| Pubmed | CMPK1 PCGF1 ADAM18 GRK7 SRC SRMS ACVR1 ACVR1B PCGF3 TUBB3 MTMR6 SULT2B1 MAPK1 KCNH5 | 6.29e-06 | 730 | 157 | 14 | 34857952 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DOCK1 ACVR1 FBXL3 STAT3 ITPR1 NLN KIAA1217 CLPTM1 TJP2 TAF9 ANKRD52 NIPBL | 6.40e-06 | 536 | 157 | 12 | 15840001 |
| Pubmed | DOCK1 ACVR1 FBXL3 STAT3 ITPR1 NLN KIAA1217 CLPTM1 TJP2 TAF9 ANKRD52 NIPBL | 6.65e-06 | 538 | 157 | 12 | 10512203 | |
| Pubmed | CMPK1 CAD COL12A1 ACLY RTN4 ACTB RNF149 ACTG1 RFC2 PFKP PAICS STAT3 MTMR6 KIDINS220 DST LOXL2 CLPTM1 TMED9 NIPBL | 6.77e-06 | 1297 | 157 | 19 | 33545068 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | PCGF1 GRK7 MAP3K14 STYK1 ACVR1B PCGF3 FBXL3 PDIK1L GTF2IRD2 IRAK3 | 8.08e-06 | 372 | 157 | 10 | 22939624 |
| Pubmed | CAD NYAP2 RAP2B SYNE1 SRC ACTB ADAM22 WDR45 DST PI4KA KIAA1217 ANKRD28 TMED9 MAPK1 NIPBL DCLK1 | 8.18e-06 | 963 | 157 | 16 | 28671696 | |
| Pubmed | CAD ACLY MCM4 CHD2 PFKP PAICS PNPT1 GTF2I DST TJP2 ANKRD28 ANKRD52 NIPBL | 9.20e-06 | 653 | 157 | 13 | 22586326 | |
| Pubmed | 9.87e-06 | 163 | 157 | 7 | 16512683 | ||
| Pubmed | PDK1 ACLY RTN4 MCM4 RFC2 STAT3 ACSL1 TUBB3 GTF2I HS2ST1 ANKRD28 CDCA7L | 9.92e-06 | 560 | 157 | 12 | 35241646 | |
| Pubmed | 1.06e-05 | 10 | 157 | 3 | 15611116 | ||
| Pubmed | Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP). | 1.06e-05 | 10 | 157 | 3 | 11266516 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAD ACLY ACTB MCM4 CHD2 RFC2 PFKP PAICS ACSL1 TUBB3 GTF2I DST PNPLA6 WASHC5 PI4KA ANKRD28 MAPK1 ANKRD52 NIPBL | 1.22e-05 | 1353 | 157 | 19 | 29467282 |
| Pubmed | Identification of FBXO25-interacting proteins using an integrated proteomics approach. | 1.24e-05 | 112 | 157 | 6 | 20473970 | |
| Pubmed | 1.45e-05 | 11 | 157 | 3 | 18499741 | ||
| Pubmed | Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-beta signaling. | 1.45e-05 | 11 | 157 | 3 | 19758997 | |
| Pubmed | DLG5 CAD RAP2B LONP2 SYNE1 ACTB CHD2 RFC2 PFKP KIDINS220 DST PNPLA6 COX5A CLPB PI4KA TMED9 TAF9 THAP12 NIPBL DCLK1 | 1.46e-05 | 1497 | 157 | 20 | 31527615 | |
| Pubmed | 1.48e-05 | 33 | 157 | 4 | 17955473 | ||
| Pubmed | 1.61e-05 | 403 | 157 | 10 | 30562941 | ||
| Pubmed | 1.80e-05 | 71 | 157 | 5 | 33541421 | ||
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 12576423 | ||
| Pubmed | DOCK1 FNBP1 CAD CYP19A1 MCM4 PFKP PAICS GTF2I TJP2 ANKRD52 NIPBL | 1.95e-05 | 503 | 157 | 11 | 16964243 | |
| Pubmed | Beta- and gamma-cytoplasmic actins are required for meiosis in mouse oocytes. | 2.02e-05 | 2 | 157 | 2 | 21778137 | |
| Pubmed | De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. | 2.02e-05 | 2 | 157 | 2 | 22366783 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 22724068 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 32088241 | ||
| Pubmed | Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer. | 2.02e-05 | 2 | 157 | 2 | 19861436 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 24144647 | ||
| Pubmed | TRIM59 Promotes Retinoblastoma Progression by Activating the p38-MAPK Signaling Pathway. | 2.02e-05 | 2 | 157 | 2 | 32744597 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36460692 | ||
| Pubmed | Regionally distinct patterns of STAT3 phosphorylation in the seminiferous epithelia of mouse testes. | 2.02e-05 | 2 | 157 | 2 | 29393534 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 32140760 | ||
| Interaction | TRPC5 interactions | 9.84e-07 | 24 | 156 | 5 | int:TRPC5 | |
| Interaction | TRPC3 interactions | 5.19e-06 | 33 | 156 | 5 | int:TRPC3 | |
| Interaction | FGFR1 interactions | DOCK1 FNBP1 DLG5 PDK1 SRC ACTB RNF149 ACTG1 PFKP STAT3 MTMR6 WASHC5 CLPTM1 TMED9 LRBA KIT HSP90AB3P | 8.45e-06 | 632 | 156 | 17 | int:FGFR1 |
| Interaction | TRPC7 interactions | 8.95e-06 | 6 | 156 | 3 | int:TRPC7 | |
| Interaction | PFN1 interactions | DOCK1 DOCK4 DLG5 ACTB RNF149 ACTG1 ARHGAP35 JMY SPAG5 KIDINS220 LOXL2 KIAA1217 TJP2 ANKRD28 ALG13 | 1.02e-05 | 509 | 156 | 15 | int:PFN1 |
| Interaction | VASP interactions | ACTB ACTG1 ARHGAP35 JMY SPAG5 ERMAP TJP2 ANKRD28 ANKRD52 NSMAF ALG13 | 1.89e-05 | 294 | 156 | 11 | int:VASP |
| Interaction | KCTD13 interactions | CAD RAP2B PDK1 ACLY SYNE1 RTN4 ACTB ACTG1 ARHGAP35 PFKP ADAM22 JMY TUBB3 KIDINS220 DST PNPLA6 COX5A WASHC5 PI4KA KIAA1217 SLC27A1 TJP2 KCNQ2 TMED9 MAPK1 DCLK1 | 2.50e-05 | 1394 | 156 | 26 | int:KCTD13 |
| Interaction | TRPC4 interactions | 2.73e-05 | 23 | 156 | 4 | int:TRPC4 | |
| Interaction | FKBP1A interactions | 2.83e-05 | 113 | 156 | 7 | int:FKBP1A | |
| Interaction | TRPC6 interactions | 4.21e-05 | 82 | 156 | 6 | int:TRPC6 | |
| Interaction | TRPC1 interactions | 7.06e-05 | 29 | 156 | 4 | int:TRPC1 | |
| Interaction | PRKCA interactions | PSAP TRPC3 SRC ACTB ACTG1 PFKFB1 ERCC8 KCNQ2 TRPV6 MAPK1 KIT IL23R | 8.24e-05 | 408 | 156 | 12 | int:PRKCA |
| Interaction | FGR interactions | 8.55e-05 | 93 | 156 | 6 | int:FGR | |
| Interaction | VEPH1 interactions | 9.51e-05 | 12 | 156 | 3 | int:VEPH1 | |
| Interaction | GTF2IRD2 interactions | 9.51e-05 | 12 | 156 | 3 | int:GTF2IRD2 | |
| Interaction | MX1 interactions | 1.01e-04 | 60 | 156 | 5 | int:MX1 | |
| Interaction | EZR interactions | DLG5 ACTB RNF149 ARHGAP35 JMY WDR45 KIDINS220 DST WASHC5 PI4KA LOXL2 ANKRD28 LRBA PHLPP2 | 1.05e-04 | 553 | 156 | 14 | int:EZR |
| Interaction | FGFR2 interactions | 1.05e-04 | 239 | 156 | 9 | int:FGFR2 | |
| Interaction | PPP1R9B interactions | ACLY RTN4 ACTB ACTG1 PFKP ADAM22 ITPR1 TUBB3 COX5A KIAA1217 TJP2 KCNQ2 ANKRD28 MAPK1 DCLK1 | 1.08e-04 | 626 | 156 | 15 | int:PPP1R9B |
| Interaction | HSP90AA1 interactions | CAD PCGF1 COL12A1 GRK7 SRC MAP3K14 STYK1 SRMS ACTG1 FNDC3A ACVR1B ACVRL1 PCGF3 FBXL3 STAT3 PDIK1L LOXL2 GUCY2D GTF2IRD2 IRAK3 MAPK1 NIPBL HSP90AB3P | 1.11e-04 | 1263 | 156 | 23 | int:HSP90AA1 |
| Interaction | LINC01554 interactions | 1.21e-04 | 142 | 156 | 7 | int:LINC01554 | |
| Interaction | ACVR2A interactions | 1.28e-04 | 100 | 156 | 6 | int:ACVR2A | |
| Interaction | HCK interactions | 1.33e-04 | 193 | 156 | 8 | int:HCK | |
| Interaction | IL23R interactions | 1.56e-04 | 14 | 156 | 3 | int:IL23R | |
| Interaction | AMOT interactions | DLG5 LONP2 ACTB ACTG1 FNDC3A SPAG5 WDR45 TJP2 ANKRD28 ANKRD52 | 1.64e-04 | 312 | 156 | 10 | int:AMOT |
| Interaction | RND2 interactions | FNBP1 DLG5 CMPK1 ARHGAP35 PFKP ITPR1 KIDINS220 DST PI4KA ABCD1 MAPK1 LRBA | 1.67e-04 | 440 | 156 | 12 | int:RND2 |
| Interaction | HOOK3 interactions | 1.81e-04 | 202 | 156 | 8 | int:HOOK3 | |
| Interaction | BAMBI interactions | 1.93e-04 | 15 | 156 | 3 | int:BAMBI | |
| Interaction | IGSF1 interactions | 1.93e-04 | 15 | 156 | 3 | int:IGSF1 | |
| Interaction | GTF2IRD2B interactions | 1.93e-04 | 15 | 156 | 3 | int:GTF2IRD2B | |
| GeneFamily | Transient receptor potential cation channels | 6.39e-07 | 28 | 109 | 5 | 249 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 7.33e-06 | 7 | 109 | 3 | 345 | |
| GeneFamily | 6-phosphofructo-2-kinases/fructose-2,6-biphosphatases | 2.14e-04 | 4 | 109 | 2 | 1077 | |
| GeneFamily | Actins | 5.32e-04 | 6 | 109 | 2 | 929 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 5.32e-04 | 6 | 109 | 2 | 699 | |
| GeneFamily | Ring finger proteins|Polycomb group ring fingers | 7.42e-04 | 7 | 109 | 2 | 61 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.26e-03 | 9 | 109 | 2 | 1230 | |
| GeneFamily | Tudor domain containing | 1.43e-03 | 37 | 109 | 3 | 780 | |
| GeneFamily | Patatin like phospholipase domain containing | 1.57e-03 | 10 | 109 | 2 | 466 | |
| GeneFamily | SH2 domain containing | 3.26e-03 | 101 | 109 | 4 | 741 | |
| GeneFamily | AAA ATPases | 4.01e-03 | 53 | 109 | 3 | 413 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FNBP1 LONP2 SYNE1 ACTB RNF149 CHD2 ARHGAP35 CCDC88B JMY FBXL3 STAT3 STAT4 ITPR1 KIDINS220 GFOD1 COMMD8 DENND4B GPCPD1 ANKRD28 MAPK1 LRBA KIT THAP12 NIPBL NSMAF | 2.62e-06 | 1492 | 156 | 25 | M40023 |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 3.19e-06 | 199 | 156 | 9 | M3186 | |
| Coexpression | GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN | 3.32e-06 | 200 | 156 | 9 | M7164 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 7.82e-06 | 168 | 156 | 8 | M6874 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 PMS1 DOCK4 TRPC1 MAP3K14 FNDC3A CTIF ACVR1 ARHGAP35 ITPR1 KIDINS220 DST TJP2 ANKRD28 NIPBL NSMAF PHLPP2 | 1.46e-05 | 856 | 156 | 17 | M4500 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DOCK4 FNBP1 DLG5 PSAP ACLY ANXA4 ACTB MCM4 PFKP PCGF3 ACSL1 WASHC5 NFIL3 KIT NSMAF ALG13 | 2.09e-05 | 790 | 156 | 16 | M12490 |
| Coexpression | GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 2.76e-05 | 200 | 156 | 8 | M7168 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | PMS1 CMPK1 CAD RAP2B ACLY ANXA4 RTN4 ACVR1 PFKP PAICS GDE1 STAT3 STAT4 ACSL1 ERCC8 GTF2I HS2ST1 CLPTM1 MAPK1 TAF9 THAP12 NSMAF | 2.96e-05 | 1399 | 156 | 22 | M535 |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 3.81e-05 | 32 | 156 | 4 | MM17 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 4.87e-05 | 34 | 156 | 4 | M45005 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 6.36e-05 | 166 | 156 | 7 | M5354 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | CAD COL12A1 TRPC6 MCM4 PAICS TRIM59 NLN DST HMCN1 SULT2B1 ANKRD28 CCNB1IP1 | 8.94e-05 | 534 | 156 | 12 | M12522 |
| Coexpression | DELACROIX_RAR_BOUND_ES | PCGF1 PDK1 SRC NR6A1 GDE1 STAT4 ITPR1 CLPB GFOD1 ANKRD28 KIT | 1.13e-04 | 465 | 156 | 11 | M2466 |
| Coexpression | ELVIDGE_HYPOXIA_BY_DMOG_UP | 1.43e-04 | 132 | 156 | 6 | M9197 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | CMTR1 LONP2 ACLY MAP3K14 PCGF3 ITPR1 ACSL1 TUBB3 NIPBL ALG13 | 1.46e-04 | 399 | 156 | 10 | M41172 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | SHLD2 COL12A1 RAP2B ANXA4 RTN4 MAP3K14 RFC2 GDE1 GTF2I DST SUSD1 NFIL3 OSBPL7 GTF2IRD2 TJP2 | 1.61e-04 | 843 | 156 | 15 | M2356 |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_UP | 1.65e-04 | 86 | 156 | 5 | M16587 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP | 1.68e-04 | 194 | 156 | 7 | M5852 | |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN | 1.73e-04 | 195 | 156 | 7 | M5857 | |
| Coexpression | SMITH_TERT_TARGETS_DN | 1.75e-04 | 87 | 156 | 5 | M1217 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN | 1.84e-04 | 197 | 156 | 7 | M8025 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | DOCK4 COL12A1 SPEG ANXA4 TRPC1 FNDC3A MTMR6 DST NFIL3 LOXL2 DAAM2 LRBA SLITRK6 CCNB1IP1 NSMAF | 1.86e-04 | 854 | 156 | 15 | M1533 |
| Coexpression | DELACROIX_RAR_BOUND_ES | PCGF1 PDK1 SRC NR6A1 GDE1 STAT4 ITPR1 CLPB GFOD1 ANKRD28 KIT | 1.88e-04 | 493 | 156 | 11 | MM1079 |
| Coexpression | GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN | 1.96e-04 | 199 | 156 | 7 | M7033 | |
| Coexpression | CAMP_UP.V1_DN | 1.96e-04 | 199 | 156 | 7 | M2719 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP | 1.96e-04 | 199 | 156 | 7 | M4063 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_DN | 2.02e-04 | 200 | 156 | 7 | M4806 | |
| Coexpression | GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN | 2.02e-04 | 200 | 156 | 7 | M8647 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP | 2.02e-04 | 200 | 156 | 7 | M3636 | |
| Coexpression | GSE17580_TREG_VS_TEFF_DN | 2.02e-04 | 200 | 156 | 7 | M3671 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 2.02e-04 | 200 | 156 | 7 | M6027 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN | 2.02e-04 | 200 | 156 | 7 | M7915 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 2.02e-04 | 200 | 156 | 7 | M9133 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP | 2.02e-04 | 200 | 156 | 7 | M9169 | |
| Coexpression | SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN | 2.38e-04 | 145 | 156 | 6 | M11513 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.74e-08 | 149 | 156 | 8 | 558a441804dbcd5b5f39a3b1933b48976711ff15 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.70e-08 | 152 | 156 | 8 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | CV-Severe-4|CV / Virus stimulation, Condition and Cluster | 2.68e-07 | 182 | 156 | 8 | c19bbc43d97c426aec37414f46f667a19b62a257 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 2.79e-07 | 183 | 156 | 8 | f10e72a2e2e6cdc1984f469a60244e5fd8a10095 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.16e-07 | 186 | 156 | 8 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.71e-07 | 190 | 156 | 8 | 693b223f6b94a46d935fbcb02d7a27340ce43154 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.02e-07 | 192 | 156 | 8 | 12f7ea575da5d650c740e6060f5dab0478e563dd | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-07 | 194 | 156 | 8 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.35e-07 | 194 | 156 | 8 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_only / Treatment groups by lineage, cell group, cell type | 5.07e-07 | 198 | 156 | 8 | 53c22e81e530d6fc272d4a45c8d1bf125feb254d | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-06 | 169 | 156 | 7 | a83e4078db91ecedee637b28b12ec38640fe45f9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-06 | 169 | 156 | 7 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-maDC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.27e-06 | 169 | 156 | 7 | f914aa8899fa170a09da31e5fad86de897ea789b | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.45e-06 | 171 | 156 | 7 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.08e-06 | 177 | 156 | 7 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.32e-06 | 179 | 156 | 7 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | CV-Severe-4|Severe / Virus stimulation, Condition and Cluster | 3.44e-06 | 180 | 156 | 7 | cf84a01e6a33e5d27ad7be1d9069a0370b5116d1 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 182 | 156 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.12e-06 | 185 | 156 | 7 | 686ed7550c6acd18e71e0076936ec5b07389adbd | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-06 | 185 | 156 | 7 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | Tuft|World / Class top | 4.27e-06 | 186 | 156 | 7 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 4.27e-06 | 186 | 156 | 7 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.74e-06 | 189 | 156 | 7 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-06 | 191 | 156 | 7 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-06 | 191 | 156 | 7 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-06 | 191 | 156 | 7 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 5.26e-06 | 192 | 156 | 7 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 5.44e-06 | 193 | 156 | 7 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.44e-06 | 193 | 156 | 7 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 5.63e-06 | 194 | 156 | 7 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.63e-06 | 194 | 156 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.82e-06 | 195 | 156 | 7 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 6.02e-06 | 196 | 156 | 7 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.43e-06 | 198 | 156 | 7 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.43e-06 | 198 | 156 | 7 | c288b29287a562460d8970264e1833801590da73 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.43e-06 | 198 | 156 | 7 | e8002972410e4803d85263ba2642e6855cef83e9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.60e-06 | 130 | 156 | 6 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 6.65e-06 | 199 | 156 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | ILEUM-inflamed-(6)_ILC-(6)_ILC3|(6)_ILC / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.65e-06 | 199 | 156 | 7 | 02879df850b0c72b57d7b22cfc43f3407e182dcb | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 6.87e-06 | 200 | 156 | 7 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 200 | 156 | 7 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 6.87e-06 | 200 | 156 | 7 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-05 | 140 | 156 | 6 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | Control-NK|World / Disease group and Cell class | 1.14e-05 | 143 | 156 | 6 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Met|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.23e-05 | 145 | 156 | 6 | 8abbc781f5f69f039617c29a5589d7b6950c2c40 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-4|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.28e-05 | 146 | 156 | 6 | 632f52780607c638b5d3dd3fb9251c719f162a35 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.38e-05 | 87 | 156 | 5 | 4274e04fa4aca85c2cefd8c5e03d0fa4a4f15536 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.38e-05 | 87 | 156 | 5 | 8b1a0bd5d6af32afaca19e9c69f86530bbaa309d | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Vwf_(Vwf)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.38e-05 | 87 | 156 | 5 | cc89f4176b70d4eb5b5bf0ff2319b5f1f9e292c0 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.38e-05 | 87 | 156 | 5 | 54cbdf80aae3595eaace20c7cbac763282558213 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L6_NP_ALM_Trh|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.44e-05 | 149 | 156 | 6 | fe9dff31a30dabd212d53d1295f9f13ff32cb217 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.50e-05 | 150 | 156 | 6 | 2ba55e51877e2e749cccdae7df5d885dc55b2587 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.74e-05 | 154 | 156 | 6 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 2.15e-05 | 160 | 156 | 6 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 2.39e-05 | 163 | 156 | 6 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-LTi-like_NCR-_ILC3|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.48e-05 | 164 | 156 | 6 | 74bf6080abd9191e3db8ee892fce84f1dcc4b775 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 164 | 156 | 6 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 164 | 156 | 6 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 164 | 156 | 6 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | COVID-CD8-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.65e-05 | 166 | 156 | 6 | 4ca8c91b03d08489f244898cf9423b9d10348bc8 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.83e-05 | 168 | 156 | 6 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Control-CD4+_T|World / Disease group and Cell class | 2.93e-05 | 169 | 156 | 6 | e330d85bd37a1bd1c3d8d29ddd8a2c1020a62a83 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.03e-05 | 170 | 156 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 173 | 156 | 6 | 2978c744d3c8dcaa2b9bb225abf846f82e8f9176 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 173 | 156 | 6 | 23d4a315a0ad5c6fc77bcfc18b6c1ff55be99e8f | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 173 | 156 | 6 | 03b50b2376d353748a32bf14a9fc8341ea61dbca | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.34e-05 | 173 | 156 | 6 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | PND28-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.34e-05 | 173 | 156 | 6 | 12da47b90aecedaa31764ff7ddb853ee39123e9d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 174 | 156 | 6 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.45e-05 | 174 | 156 | 6 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.56e-05 | 175 | 156 | 6 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.80e-05 | 177 | 156 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-05 | 178 | 156 | 6 | a9ba4089413b1c55d667ce836b6972ca572ee2b8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.92e-05 | 178 | 156 | 6 | 13dfd28a80889c2dacdc65b94a41bb9762dc409d | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 4.04e-05 | 179 | 156 | 6 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 4.17e-05 | 180 | 156 | 6 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 4.17e-05 | 180 | 156 | 6 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 180 | 156 | 6 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 182 | 156 | 6 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 4.43e-05 | 182 | 156 | 6 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | ILEUM-inflamed-(5)_IgA_plasma_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.57e-05 | 183 | 156 | 6 | a113558ca4220bac31f9336033dff82a618d9258 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 4.57e-05 | 183 | 156 | 6 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 4.71e-05 | 184 | 156 | 6 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-4|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.71e-05 | 184 | 156 | 6 | d9659d1e4465fec68f48a22edef443f354f6c7cf | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.71e-05 | 184 | 156 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 184 | 156 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | CV-Moderate-4|Moderate / Virus stimulation, Condition and Cluster | 4.86e-05 | 185 | 156 | 6 | 4a3ce0c603c2ffe11f0f00775b6af4f6d9a6070a | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.88e-05 | 113 | 156 | 5 | ec4b89e727e1b921b9cb17443774955b95814dd4 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-05 | 186 | 156 | 6 | e5014443e9d6e25943308483e20d48b776ae5373 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.00e-05 | 186 | 156 | 6 | c7e2134454ab5d0885050dd1bb3c3bd15bf497ac | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-05 | 186 | 156 | 6 | affc246a1091e44dc85a5e237c778a7541d5a2b4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-05 | 186 | 156 | 6 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | LPS_only-Hematopoietic_Meg-Ery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-05 | 186 | 156 | 6 | 40d1e15402fdfb3b5ae850a2070cd4b68fda3159 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 187 | 156 | 6 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | CD8+_Memory_T_cell-CV-4|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.16e-05 | 187 | 156 | 6 | 9c2fc2f259fa7d3a65fb99c295ac378e03d9aa6c | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 187 | 156 | 6 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 187 | 156 | 6 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | Tuft-tuft-2|World / Class top | 5.16e-05 | 187 | 156 | 6 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| Drug | wartmannin | MYH3 PSAP TRPC1 TRPC6 SRC ACTB SRMS ACTG1 FNDC3A PFKFB1 PFKFB4 STAT3 MTMR6 PIK3CG PI4KA KCNQ2 TRPV6 MAPK1 LRBA KIT THAP12 | 1.56e-07 | 811 | 155 | 21 | CID000005691 |
| Drug | $l^{1}-borane | 5.15e-07 | 44 | 155 | 6 | CID006397184 | |
| Drug | carbachol | MYH3 TRPC7 ACLY TRPC1 TRPC3 TRPC6 SRC ACTB SRMS ACTG1 ITPR1 PIK3CG PI4KA GUCY2D IRAK3 TRPV6 MAPK1 LRBA | 1.11e-06 | 688 | 155 | 18 | CID000002551 |
| Drug | Adenosine triphosphate | 2.79e-06 | 33 | 155 | 5 | DB00171 | |
| Drug | AC1L1BDQ | 2.98e-06 | 173 | 155 | 9 | CID000001394 | |
| Drug | AC1OAGFB | FNBP1 RAP2B TRPC1 TRPC3 TRPC6 SRC ACTB ACTG1 ARHGAP35 ITPR1 PIK3CG PI4KA KCNQ2 TRPV6 NSMAF | 4.40e-06 | 539 | 155 | 15 | CID006857345 |
| Drug | AC1L1KMJ | COL12A1 RAP2B TRPC1 SRC ACTB SRMS ACTG1 FNDC3A TUBB3 DST PI4KA TJP2 MAPK1 LRBA | 4.97e-06 | 476 | 155 | 14 | CID000030956 |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | 5.87e-06 | 188 | 155 | 9 | 2161_DN | |
| Drug | imatinib | CYP19A1 SRC ACTB STYK1 SRMS ACTG1 ACVR1 ACVR1B ACVRL1 STAT3 MAPK1 KIT TP73 | 8.19e-06 | 430 | 155 | 13 | CID000005291 |
| Drug | D-myo-inositol-1,4,5-triphosphate | RAP2B TRPC7 TRPC1 TRPC3 TRPC6 SRC ACTB SRMS ACTG1 FNDC3A ITPR1 PI4KA TRPV6 MAPK1 LRBA | 8.24e-06 | 568 | 155 | 15 | CID000000806 |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.30e-06 | 199 | 155 | 9 | 2231_DN | |
| Drug | glipentide | 1.06e-05 | 7 | 155 | 3 | CID000065779 | |
| Drug | LY294002 | MYH3 TRPC6 SRC ACTB SRMS ACTG1 FNDC3A PFKP STAT3 ITPR1 MTMR6 IL36RN PIK3CG PI4KA MAPK1 LRBA THAP12 | 1.43e-05 | 748 | 155 | 17 | CID000003973 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | FNBP1 COL12A1 NYAP2 TRPC7 ACER1 GGT6 CYP19A1 MCM4 PFKFB1 PFKP TRIM59 ADAM22 STAT3 ITPR1 SULT2B1 GFOD1 PIK3CG PCDH11X KCNQ2 TMED9 MAPK1 LRBA CDCA7L UNC80 ALG13 | 1.44e-05 | 1441 | 155 | 25 | ctd:C009828 |
| Drug | triphosphoinositide | 1.86e-05 | 273 | 155 | 10 | CID009543520 | |
| Drug | XeC compound | 2.37e-05 | 84 | 155 | 6 | CID000005701 | |
| Drug | Nb d | 2.62e-05 | 174 | 155 | 8 | CID000445938 | |
| Drug | magnesium | CNNM2 CAD TRPC1 TRPC3 RTN4 TRPC6 SRC ACTB SRMS ACTG1 PFKFB1 PFKFB4 ARHGAP35 RFC2 PFKP PAICS TUBB3 IL36RN COX5A CLPB TRPV6 LRBA DNAH9 | 3.29e-05 | 1325 | 155 | 23 | CID000000888 |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.48e-05 | 181 | 155 | 8 | 1537_UP | |
| Drug | chelerythrine | TRPC7 TRPC1 TRPC6 SRC ACTB ACTG1 ITPR1 PIK3CG MAPK1 LRBA THAP12 | 3.50e-05 | 357 | 155 | 11 | CID000002703 |
| Drug | HBF4 | 3.59e-05 | 10 | 155 | 3 | CID000028118 | |
| Drug | AC1MU1S9 | TRPC3 SRC ACTB ACTG1 ARHGAP35 ITPR1 GTF2I PIK3CG GUCY2D EDDM3B IRAK3 MAPK1 LRBA THAP12 | 3.84e-05 | 572 | 155 | 14 | CID000003733 |
| Drug | Hypertensin II | TRPC7 TRPC1 TRPC6 ACTB ACTG1 ACVR1 ACVR1B ACVRL1 PAICS STAT3 DST MAPK1 | 3.94e-05 | 429 | 155 | 12 | CID000025476 |
| Drug | lanthanum | 4.14e-05 | 136 | 155 | 7 | CID000023926 | |
| Drug | 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL | 4.60e-05 | 2 | 155 | 2 | DB07335 | |
| Drug | AC1L1IZ2 | 4.63e-05 | 304 | 155 | 10 | CID000004795 | |
| Drug | morin | 4.70e-05 | 58 | 155 | 5 | ctd:C008548 | |
| Drug | POPC | ACLY ANXA4 ACVRL1 GDE1 PNPLA6 PIK3CG PI4KA LOXL2 ABCB11 PNPLA7 | 4.90e-05 | 306 | 155 | 10 | CID000065167 |
| Drug | fructose 2-phosphorothioate 6-phosphate | 4.91e-05 | 11 | 155 | 3 | CID000195184 | |
| Drug | malaoxon | 4.91e-05 | 11 | 155 | 3 | ctd:C100082 | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.91e-05 | 190 | 155 | 8 | 3833_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.89e-05 | 195 | 155 | 8 | 7394_DN | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 6.11e-05 | 196 | 155 | 8 | 6905_DN | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A | 6.33e-05 | 197 | 155 | 8 | 6903_DN | |
| Drug | glycerophosphoinositol | 6.49e-05 | 62 | 155 | 5 | CID000167572 | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 2242_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Up 200; 5.4uM; HL60; HT_HG-U133A | 6.56e-05 | 198 | 155 | 8 | 2909_UP | |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | 6.80e-05 | 199 | 155 | 8 | 366_DN | |
| Drug | BAPTA | 7.88e-05 | 324 | 155 | 10 | CID000104751 | |
| Drug | 2,4,4'-trichlorobiphenyl | FNBP1 COL12A1 NYAP2 TRPC7 ACER1 GGT6 MCM4 PFKFB1 PFKP TRIM59 ADAM22 ITPR1 SULT2B1 GFOD1 PIK3CG PCDH11X KCNQ2 TMED9 MAPK1 LRBA CDCA7L UNC80 ALG13 | 8.58e-05 | 1411 | 155 | 23 | ctd:C081766 |
| Drug | AC1L1KC5 | TRPC7 TRPC1 TRPC3 TRPC6 ACTB ACTG1 ITPR1 GTF2I NFIL3 PI4KA TRPV6 MAPK1 LRBA | 8.82e-05 | 541 | 155 | 13 | CID000005428 |
| Drug | mantATP | 9.18e-05 | 35 | 155 | 4 | CID000123756 | |
| Drug | Flavonoids | COL12A1 ACLY SPEG ANXA4 CYP19A1 TRPC1 RTN4 TRPC6 SRC PFKFB1 CNTN6 SPAG5 ITPR1 CLPB GUCY2D TJP2 TRPV6 MAPK1 CNGA4 DCLK1 | 9.31e-05 | 1136 | 155 | 20 | ctd:D005419 |
| Drug | strontium | 1.01e-04 | 68 | 155 | 5 | CID000104798 | |
| Drug | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole | 1.07e-04 | 14 | 155 | 3 | ctd:C063159 | |
| Drug | Asbestos, Crocidolite | DOCK4 MYH3 CNNM2 COL12A1 SYNE1 SRC NR4A3 CHD2 NR6A1 TRIM59 STAT4 DST IL36RN SULT2B1 NFIL3 GUCY2D TAS1R1 GPCPD1 MAPK1 DCLK1 CDH13 | 1.07e-04 | 1241 | 155 | 21 | ctd:D017638 |
| Drug | AC1L19C4 | 1.08e-04 | 69 | 155 | 5 | CID000000483 | |
| Drug | ATP betaS | 1.25e-04 | 162 | 155 | 7 | CID005311341 | |
| Drug | Maneb | 1.29e-04 | 344 | 155 | 10 | ctd:D008344 | |
| Drug | aspirin | PMS1 COL12A1 PSAP ACLY MAP3K14 ACVRL1 STAT3 GTF2I DST IL36RN TMED9 ABCD1 MAPK1 | 1.31e-04 | 563 | 155 | 13 | CID000002244 |
| Drug | 1-oleoyl-2-acetylglycerol | 1.33e-04 | 15 | 155 | 3 | ctd:C038237 | |
| Disease | nicotine dependence (implicated_via_orthology) | 3.24e-07 | 12 | 152 | 4 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | B4GAT1 SYNE1 CYP19A1 SRC RNF149 CTIF ACVR1 PFKFB4 STAT3 CNTN6 STAT4 TUBB3 PER3 LOXL2 LRBA KIT DNAH9 NIPBL TP73 | 2.92e-06 | 1074 | 152 | 19 | C0006142 |
| Disease | Epilepsy | 2.21e-05 | 109 | 152 | 6 | C0014544 | |
| Disease | Baraitser-Winter syndrome | 2.64e-05 | 2 | 152 | 2 | cv:C1853623 | |
| Disease | fibrodysplasia ossificans progressiva (implicated_via_orthology) | 2.64e-05 | 2 | 152 | 2 | DOID:13374 (implicated_via_orthology) | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 2.64e-05 | 2 | 152 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 2.64e-05 | 2 | 152 | 2 | C1853623 | |
| Disease | Bipolar Disorder | TRPC7 SYNE1 TRPC3 ACTB FBXL3 CNTN6 ITPR1 PER3 KCNQ2 MAPK1 DCLK1 | 3.94e-05 | 477 | 152 | 11 | C0005586 |
| Disease | rectum adenocarcinoma (is_implicated_in) | 7.88e-05 | 3 | 152 | 2 | DOID:1996 (is_implicated_in) | |
| Disease | polymyositis (is_implicated_in) | 7.88e-05 | 3 | 152 | 2 | DOID:0080745 (is_implicated_in) | |
| Disease | dermatomyositis (is_implicated_in) | 7.88e-05 | 3 | 152 | 2 | DOID:10223 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 7.92e-05 | 268 | 152 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | B4GAT1 SYNE1 CYP19A1 SRC ACVR1 STAT3 TUBB3 PER3 LOXL2 KIT TP73 | 9.26e-05 | 525 | 152 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | B4GAT1 SYNE1 CYP19A1 SRC ACVR1 STAT3 TUBB3 PER3 LOXL2 KIT TP73 | 9.26e-05 | 525 | 152 | 11 | C1257931 |
| Disease | Mammary Neoplasms | B4GAT1 SYNE1 CYP19A1 SRC ACVR1 STAT3 TUBB3 PER3 LOXL2 KIT TP73 | 9.57e-05 | 527 | 152 | 11 | C1458155 |
| Disease | Breast Carcinoma | B4GAT1 SYNE1 CYP19A1 SRC ACVR1 STAT3 TUBB3 PER3 LOXL2 KIT TP73 | 1.15e-04 | 538 | 152 | 11 | C0678222 |
| Disease | Neurodevelopmental Disorders | 1.23e-04 | 93 | 152 | 5 | C1535926 | |
| Disease | 7-methylxanthine measurement | 1.57e-04 | 4 | 152 | 2 | EFO_0021176 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 3.19e-04 | 26 | 152 | 3 | DOID:234 (is_implicated_in) | |
| Disease | urate measurement, bone density | FNBP1 SYNE1 TRPC6 ITPR1 RANBP17 KIDINS220 LOXL2 DNAH9 DCLK1 CDH13 KCNH5 | 3.82e-04 | 619 | 152 | 11 | EFO_0003923, EFO_0004531 |
| Disease | hemoglobin A1 measurement | DLG5 CNNM2 NYAP2 TENT5C PFKP PCGF3 TRIM59 ACSL1 ABCB11 TRPV6 | 3.82e-04 | 520 | 152 | 10 | EFO_0007629 |
| Disease | peripheral neuropathy, response to bortezomib | 3.90e-04 | 6 | 152 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | renal cell carcinoma (is_implicated_in) | 4.51e-04 | 69 | 152 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | visceral:subcutaneous adipose tissue ratio | 4.77e-04 | 70 | 152 | 4 | EFO_0004767 | |
| Disease | pulmonary hypertension (is_implicated_in) | 4.91e-04 | 30 | 152 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | Uveoretinal Coloboma | 5.44e-04 | 7 | 152 | 2 | C4554007 | |
| Disease | Intrahepatic Cholestasis | 5.44e-04 | 7 | 152 | 2 | C0008372 | |
| Disease | Tinnitus | 5.80e-04 | 130 | 152 | 5 | HP_0000360 | |
| Disease | psoriasis (is_implicated_in) | 7.13e-04 | 34 | 152 | 3 | DOID:8893 (is_implicated_in) | |
| Disease | Leprosy | 7.23e-04 | 8 | 152 | 2 | C0023343 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 7.23e-04 | 8 | 152 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Moyamoya disease (implicated_via_orthology) | 7.23e-04 | 8 | 152 | 2 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 7.23e-04 | 8 | 152 | 2 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 7.23e-04 | 8 | 152 | 2 | DOID:0081112 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 7.23e-04 | 8 | 152 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 7.23e-04 | 8 | 152 | 2 | DOID:14004 (implicated_via_orthology) | |
| Disease | Behcet's disease (is_implicated_in) | 8.45e-04 | 36 | 152 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Animal Mammary Neoplasms | 8.64e-04 | 142 | 152 | 5 | C0024667 | |
| Disease | stomach cancer (is_marker_for) | 8.64e-04 | 142 | 152 | 5 | DOID:10534 (is_marker_for) | |
| Disease | Mammary Carcinoma, Animal | 8.64e-04 | 142 | 152 | 5 | C1257925 | |
| Disease | Epilepsy, Cryptogenic | 8.67e-04 | 82 | 152 | 4 | C0086237 | |
| Disease | Cardiomegaly | 8.67e-04 | 82 | 152 | 4 | C0018800 | |
| Disease | Awakening Epilepsy | 8.67e-04 | 82 | 152 | 4 | C0751111 | |
| Disease | Aura | 8.67e-04 | 82 | 152 | 4 | C0236018 | |
| Disease | Cardiac Hypertrophy | 8.67e-04 | 82 | 152 | 4 | C1383860 | |
| Disease | Congenital ocular coloboma (disorder) | 9.27e-04 | 9 | 152 | 2 | C0009363 | |
| Disease | Dystonia | 1.04e-03 | 86 | 152 | 4 | C0013421 | |
| Disease | age at menarche | 1.06e-03 | 594 | 152 | 10 | EFO_0004703 | |
| Disease | Inherited neuropathies | 1.15e-03 | 40 | 152 | 3 | C0598589 | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:10486 (implicated_via_orthology) | |
| Disease | Congenital neurologic anomalies | 1.15e-03 | 10 | 152 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.15e-03 | 10 | 152 | 2 | C0265541 | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.15e-03 | 10 | 152 | 2 | DOID:13832 (implicated_via_orthology) | |
| Disease | Mammary Neoplasms, Experimental | 1.28e-03 | 155 | 152 | 5 | C0024668 | |
| Disease | psoriatic arthritis (is_implicated_in) | 1.41e-03 | 11 | 152 | 2 | DOID:9008 (is_implicated_in) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.42e-03 | 43 | 152 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | Carcinomatosis | 1.59e-03 | 163 | 152 | 5 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 1.59e-03 | 163 | 152 | 5 | C0205697 | |
| Disease | Undifferentiated carcinoma | 1.59e-03 | 163 | 152 | 5 | C0205698 | |
| Disease | Anaplastic carcinoma | 1.59e-03 | 163 | 152 | 5 | C0205696 | |
| Disease | Carcinoma | 1.64e-03 | 164 | 152 | 5 | C0007097 | |
| Disease | alcohol consumption measurement | DOCK1 DLG5 CMPK1 CAD COL12A1 NYAP2 RTN4 ACTG1 NR6A1 MMRN1 RANBP17 KIT DCLK1 CDH13 PHLPP2 | 1.94e-03 | 1242 | 152 | 15 | EFO_0007878 |
| Disease | Sjogren's Syndrome | 1.98e-03 | 13 | 152 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 1.98e-03 | 13 | 152 | 2 | C0086981 | |
| Disease | lifestyle measurement, depressive symptom measurement | 2.16e-03 | 105 | 152 | 4 | EFO_0007006, EFO_0010724 | |
| Disease | Fibrosis | 2.20e-03 | 50 | 152 | 3 | C0016059 | |
| Disease | Cirrhosis | 2.20e-03 | 50 | 152 | 3 | C1623038 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.29e-03 | 447 | 152 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Spastic Paraplegia, Hereditary | 2.30e-03 | 14 | 152 | 2 | C0037773 | |
| Disease | precuneus cortex volume measurement | 2.30e-03 | 14 | 152 | 2 | EFO_0010326 | |
| Disease | BMI-adjusted adiponectin measurement | 2.65e-03 | 15 | 152 | 2 | EFO_0007737 | |
| Disease | Williams-Beuren syndrome (implicated_via_orthology) | 2.65e-03 | 15 | 152 | 2 | DOID:1928 (implicated_via_orthology) | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 2.65e-03 | 15 | 152 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | Blood Platelet Disorders | 3.02e-03 | 16 | 152 | 2 | C0005818 | |
| Disease | ovarian cancer (is_implicated_in) | 3.04e-03 | 56 | 152 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Psoriasis | 3.20e-03 | 57 | 152 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 3.20e-03 | 57 | 152 | 3 | C0030246 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 3.41e-03 | 17 | 152 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | ulcerative colitis (is_implicated_in) | 3.41e-03 | 17 | 152 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | Sjogren syndrome | 3.70e-03 | 60 | 152 | 3 | EFO_0000699 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 3.70e-03 | 60 | 152 | 3 | MONDO_0005148, MONDO_0005277 | |
| Disease | glucuronate measurement | 3.82e-03 | 18 | 152 | 2 | EFO_0010486 | |
| Disease | Hypertrophy | 3.82e-03 | 18 | 152 | 2 | C0020564 | |
| Disease | Post-Traumatic Osteoporosis | 3.88e-03 | 61 | 152 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 3.88e-03 | 61 | 152 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 3.88e-03 | 61 | 152 | 3 | C0001787 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.05e-03 | 125 | 152 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.05e-03 | 125 | 152 | 4 | C1879321 | |
| Disease | Osteoporosis | 4.25e-03 | 63 | 152 | 3 | C0029456 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 4.26e-03 | 19 | 152 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 4.26e-03 | 19 | 152 | 2 | EFO_0003100, GO_1902519 | |
| Disease | sarcoidosis | 4.44e-03 | 64 | 152 | 3 | MONDO_0019338 | |
| Disease | lobe attachment | 4.46e-03 | 207 | 152 | 5 | EFO_0007667 | |
| Disease | Astigmatism | 4.53e-03 | 129 | 152 | 4 | HP_0000483 | |
| Disease | diet measurement, body mass index | 4.71e-03 | 20 | 152 | 2 | EFO_0004340, EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSPQELEKEYLLMVG | 26 | Q8NAT2 | |
| ESYEDLVQRLEPVIM | 366 | P16118 | |
| GYVDSIEDLKMVEPI | 131 | P56851 | |
| GYVPEIVISEMDIKQ | 571 | Q9NP73 | |
| LVEKIMDQYRVLEPV | 1291 | A6NC98 | |
| SEEMLGEIVRTIYQK | 406 | O43310 | |
| LVDANYEMPGETLKV | 226 | Q8TDN7 | |
| VYRGLLKTTMDPNDV | 81 | O43505 | |
| EKIENIYMRSEPVAQ | 571 | P33121 | |
| GTKRYMAPEVLDETI | 376 | P36896 | |
| YPGIADRMQKEITAL | 306 | P60709 | |
| YPGIADRMQKEITAL | 306 | P63261 | |
| SERKMIYIITIDGQP | 41 | Q9Y3Q7 | |
| VGTKRYMAPEVLDET | 376 | Q04771 | |
| PRNVEEETKYIELMI | 231 | Q9P0K1 | |
| VVKYLLDLGVDMNEP | 221 | O15084 | |
| YGDNTKEIPMERVIA | 1176 | O95342 | |
| GTKRYMAPEVLDEQI | 371 | P37023 | |
| PTVLYDVQELRRAMK | 86 | P09525 | |
| VVKYLLRMGAEIDEP | 221 | Q8NB46 | |
| EGMLSVVKPLDYEIS | 421 | P55290 | |
| QLGELVMVKEYPEVI | 341 | Q9H2T7 | |
| VMVKEYPEVIRLIAN | 346 | Q9H2T7 | |
| YERVPMILVGNKVDL | 106 | P61225 | |
| DRTMQDIVYKLVPGL | 71 | Q3KNV8 | |
| DIVYKLVPGLQEAEM | 76 | Q3KNV8 | |
| DVIPTMAQGVIEYKE | 151 | Q15118 | |
| QVIYPDSVEDMQRKG | 556 | P33897 | |
| RYEFLMLGIQPVIDK | 301 | Q86T65 | |
| IDITEPLYMQRLGEI | 186 | P33991 | |
| YVMKDPETRQLVLQT | 546 | P33991 | |
| RAPTIEQMKDVYIVQ | 91 | P28482 | |
| VKVPDMAEIQSRLAY | 1191 | Q8IY17 | |
| GIPDQMTLKTIYERI | 991 | Q9ULH0 | |
| LLDRMEIIQVPGYTQ | 501 | Q86WA8 | |
| LKEMDPSRQSYVLVG | 166 | A8MXT2 | |
| IKISMENDYLGPRRI | 401 | Q8N9B5 | |
| TKPEILTYDRLVNGM | 411 | P10721 | |
| YAMLELTPEEVVQRV | 746 | Q02846 | |
| GPESYVAEMIKERNL | 2666 | Q14643 | |
| QLIDLAEEYKRMGVP | 126 | Q9Y217 | |
| QTMTYEQPKEAIVIR | 661 | Q13201 | |
| VSVDMEKLQPLYETL | 6091 | Q03001 | |
| VRKQGFEVVYMTEPI | 376 | Q58FF7 | |
| QVPKGLSERVMDYIV | 496 | Q8NCM2 | |
| RKRTPVMEGYVEVKE | 196 | Q9Y4K0 | |
| DVPTELYLVMELVKG | 456 | O15075 | |
| LMTYQVPERVKEVVL | 1116 | P56645 | |
| KESLRPYDVMDVIEQ | 556 | O43526 | |
| RVLPGKYLEEIATQM | 481 | Q01813 | |
| QIIKQEPMELESYTR | 216 | Q16649 | |
| YEDLVQRLEPVIMEL | 366 | Q16877 | |
| PNMPKAVYIEDVIER | 1321 | Q6KC79 | |
| EEVYVEMLKPRDGVR | 1561 | Q8TDM6 | |
| GVTYKEFNIPLEMLR | 316 | P42356 | |
| SVLMVSKYRDILEPQ | 1541 | P50851 | |
| TEGLLTQKRYEEVMV | 556 | Q05C16 | |
| MELATRYQIPKEVAD | 1 | Q96GN5 | |
| MPEEYIRQGKLSIKT | 341 | Q9Y616 | |
| EEPVYIEMVGNILRD | 241 | Q9P242 | |
| KNYTIREEMPENVLI | 26 | Q9BZA7 | |
| MYLRRPTEESVEQGK | 256 | Q8NGP4 | |
| GEVKPYSIEMSREEL | 151 | Q9NX08 | |
| EKYPETLVRVVQIIM | 256 | Q6ZV29 | |
| INTLDIEPVEGRYML | 46 | Q13216 | |
| EPVNIMELYLGAKES | 81 | Q9UBH0 | |
| LRYIEAPKLMVVQSE | 696 | Q96RW7 | |
| ILPVMKVENERYENG | 686 | O43422 | |
| EDLGALKIPEQYRMT | 526 | O15350 | |
| LPEVIYKMRQTDRDV | 206 | Q9NZC3 | |
| QGKSEIYPELMDLRS | 526 | Q9NPB8 | |
| GYQRQMVPREEIKST | 1381 | Q6ZP82 | |
| EKVEKEYGVRIMPSS | 1606 | Q14185 | |
| QLGLDLVPRKEYAMV | 156 | Q8N1I0 | |
| GYMPNEVELEVIIQR | 66 | Q86V35 | |
| YQPVVDLVMRKALED | 366 | P11511 | |
| MIENLQPETKYRISV | 961 | Q99715 | |
| MKTYAEVDRQVIPII | 231 | Q96RU3 | |
| QKELEEIYMLPRIRS | 1061 | O14647 | |
| SIMEEVLIPDQKYSL | 391 | Q9UKT7 | |
| MSPIEKDEPREVYQG | 701 | Q9Y2H6 | |
| MERAEEPVVYQKLLP | 1 | Q6P531 | |
| LILKGVSEYMIPSEE | 721 | Q8N3K9 | |
| QVLYVDPMITEIKEI | 426 | Q5VWK5 | |
| QRTDGVMGEYEPKIE | 216 | Q9UQ52 | |
| GKVVLPDEVCYRVLM | 806 | O75064 | |
| VLEEVQRSPVGYAMK | 196 | Q8NEG0 | |
| IERGKMEYVFELDVP | 126 | Q92636 | |
| LQSTKPIIDLYEEMG | 156 | P30085 | |
| TPLDYAREGEVMKLL | 301 | Q9H078 | |
| LMAKVEERTPYIVVA | 4241 | Q9NYC9 | |
| GIVYRDMKPENVLLD | 311 | Q8WTQ7 | |
| VPYEKMLRDQSAVVV | 131 | Q86UP8 | |
| VPYEKMLRDQSAVVV | 131 | Q6EKJ0 | |
| VPYEKMLRDQSAVVV | 136 | P78347 | |
| RKGINTLVTYDMVPE | 71 | P20674 | |
| LLRMIEVVEDNYPET | 401 | O43304 | |
| GLVPKSLYMTEEEQE | 486 | O43304 | |
| KTEVMLLNPYRVEEA | 741 | P54277 | |
| PDMNPIRVKEVYRLE | 696 | Q8N1G2 | |
| DRVMQDIVYKLVPGL | 101 | Q9BSM1 | |
| PEEQEALYMKGRELT | 371 | Q9BZF2 | |
| LVTKDGQPVRYDMEV | 901 | Q99558 | |
| VYQMQRPLIKVEEGR | 76 | Q92570 | |
| EIRYIAGKMVNVPLE | 446 | Q15406 | |
| QDEDLMPEYKGRTVL | 86 | Q96PL5 | |
| SPIEVEYSQAEMKIL | 911 | A6NKG5 | |
| EKIPLQMEELSTAVY | 826 | Q9NQC3 | |
| QILKDMGITEYEPRV | 21 | Q9HBM6 | |
| QILKDMGITEYEPRV | 21 | Q16594 | |
| ETGKYLRLPQLVDMA | 356 | P12931 | |
| EEAVDPLGNYMVKTI | 116 | Q96R06 | |
| KVIYMGRNPRDVVVS | 141 | O00204 | |
| ETLMYSRPRKVLVEQ | 801 | Q9H5Y7 | |
| DIEQRVPVMDAQYKI | 751 | Q8NF91 | |
| PAFVRMKQLIEEGYV | 126 | Q9NXC2 | |
| MVSSQPKYDLIREVG | 1 | Q8N165 | |
| EEDMVIIYNRVPKTA | 71 | Q7LGA3 | |
| YGDETKQLRMPNEIT | 191 | Q5T5P2 | |
| NMETEPKASYGEIRI | 271 | Q86V20 | |
| DNRTLVVKPEDVYAM | 66 | P11055 | |
| ETGVRIYNVEPLMEK | 26 | Q9Y484 | |
| EPVYIVTELMRKGNL | 296 | Q9H3Y6 | |
| MYLRRPTEESVEQGK | 256 | Q8NGP3 | |
| IDGEYVVNPTRKEMS | 196 | Q8TCS8 | |
| KMYELSLRPIEGNVR | 631 | Q9NRY4 | |
| RPTDQEEIKTLERYM | 256 | Q5VWP2 | |
| VLRYQDTPGVKMIVV | 701 | P53396 | |
| EYKAMVLAGLRPEIV | 71 | Q9NPC3 | |
| EMIKRAEDYGPVEVI | 221 | O96005 | |
| EYPQAQTIMEEKGRE | 456 | Q8IV77 | |
| EMLRVTDPYNDLVKE | 416 | Q9H8M5 | |
| EVKYIVERTMLDFPQ | 96 | Q9BYT8 | |
| MELENYKQPVVLRED | 1 | P48736 | |
| IEEIPDETMVIGNYR | 51 | Q9BVK6 | |
| EKLPLYMVLEDVAQG | 186 | Q6J9G0 | |
| TIVKLMERIQNPEYS | 141 | P48995 | |
| YRDLKEVTPEGLQMV | 231 | P22234 | |
| YPESGTLEMNVKDLR | 216 | Q96PU4 | |
| IMISYPKGREILELV | 161 | Q8NC42 | |
| AVLYLLEIPKGEMVT | 571 | Q9UDY2 | |
| YGVMLLVIDQKIEGE | 146 | Q12768 | |
| KEGYLREEMVLDNIP | 346 | Q12768 | |
| LIKAAPILTEEMYGD | 1576 | Q8N2C7 | |
| LRTIPNDKYQVETMV | 186 | Q7RTX1 | |
| SQIPEVYEKLTMLDR | 381 | Q6ZVD8 | |
| AMLDKPDIVYVVEGQ | 1391 | Q15772 | |
| VYPIRLVKVNEDTME | 416 | Q6PCB7 | |
| QSRYLEKPMEIARIV | 91 | P40763 | |
| ILRDYKVIMAENIPE | 641 | Q14765 | |
| SYVISIKGQRLDPME | 326 | Q6UWL2 | |
| AYMTPKDDIRLVGEL | 416 | Q9H1D0 | |
| LISKVREEYPDRIMN | 151 | Q13509 | |
| RLMNVIEKERVPYTD | 201 | P35250 | |
| DSYLPVILDIIKGEM | 111 | P07602 | |
| LPDTDVLYMTRIQKE | 2136 | P27708 | |
| YVTVGLMDPLCERKE | 21 | Q3LFD5 | |
| LEQMAVIYKEIPLGE | 41 | Q9UC06 | |
| AEYGNIPVVRKMLEE | 106 | Q9Y210 | |
| PVVILTGYMDEELAK | 211 | Q5SRN2 | |
| QEYTPQIERMKEIRE | 216 | Q8IWR1 | |
| EYGNIPVVRKMLEES | 36 | Q13507 | |
| AEYGNIPVVRKMLEE | 51 | Q9HCX4 |